Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe in Homozygous Sitosterolemia
NCT00045812Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ezetimibe in sitosterolemia, sponsored by National Heart, Lung, and Blood Institute. Started Mar 2001; status: completed.
02
Drugs
ezetimibe
03
Conditions
sitosterolemia
Beyond the preview
Go deeper on NCT00045812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045812.